Development of a Machine-learning Based, Remote-Monitoring System for the Automated Detection of the Periodic Acoustic Signal Associated With the Bruit of an AV Access

The SmartPatch (Alio, Inc.) was cleared by the Food and Drug Administration (FDA) in March of 2023 as a wearable device to non-invasively assess heart rate, skin temperature, hemoglobin, hematocrit, and as a qualitative indicator of abnormal potassium levels. The device also has a microphone that is directly in contact with an arteriovenous (AV) access, simultaneously collecting a 15-second, reviewable acoustic recording of the AV access.

Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: David R. Whittaker, Forrest Miller, Nell Shimasaki, Samit Gupta, David Kuraguntla Source Type: research